semaglutide and kidney failure Effects of on CKD in Patients With Type 2 Diabetes In FLOW, semaglutide, a GLP-1

Salybekov, A

With GLP-1 medications like semaglutide and tirzepatide making headlines, many Americans are still unclear on how these treatments work, what the FDA allows, and where to find safe information

While the National Institutes of Health (NIH) supports the clinical benefits of these medications, the economic argument has not translated into the sweeping coverage expansion that patients need

Patients with complex comorbidities or polypharmacy may require additional evaluation or may be referred back to traditional in-office care if Brello's telehealth scope is insufficient

Vision loss concerns throw natural alternatives in the spotlight Fear of side-effects is often only one among several barriers to taking GLP-1 drugs